BridgeBio Pharma (BBIO) Retained Earnings (2018 - 2026)
BridgeBio Pharma (BBIO) reported Retained Earnings of -$4.0 billion for Q1 2026, down 293.68% sequentially from $2.1 billion in Q4 2025.
BridgeBio Pharma (BBIO) Retained Earnings (2018 - 2026) Analysis & Trends
BridgeBio Pharma (BBIO) has 9 years of Retained Earnings data on file, last reported at -$4.0 billion in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings changed N/A year-over-year to -$4.0 billion; the trailing twelve-month figure through Mar 2026 stood at -$4.0 billion (changed N/A YoY), and the FY2025 full-year result was $2.1 billion, up 25720475.0% from the prior year.
- Retained Earnings declined to -$4.0 billion in Q1 2026, from $2.1 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $2.1 billion in Q4 2025 to a low of -$4.0 billion in Q1 2026.
- A 5-year average of -$1.5 billion and a median of -$1.7 billion in 2022 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 25720475.0% in 2025, while the deepest fall reached 86139600.0% in 2025.
- Tracing BBIO's Retained Earnings over 5 years: stood at -$328000.0 in 2022, then tumbled by 780540.55% to -$2.6 billion in 2023, then soared by 100.0% to $8000.0 in 2024, then surged by 25720475.0% to $2.1 billion in 2025, then slumped by 293.68% to -$4.0 billion in 2026.
- Business Quant data shows BBIO's Retained Earnings at -$4.0 billion in Q1 2026, $2.1 billion in Q4 2025, and -$3.6 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn | -3.99 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.99 Bn |
| Dec 31, 2025 | 2.06 Bn |
| Sep 30, 2025 | -3.63 Bn |
| Jun 30, 2025 | -3.45 Bn |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | -2.56 Bn |
| Sep 30, 2023 | -2.39 Bn |
| Jun 30, 2023 | -2.22 Bn |
| Mar 31, 2023 | -2.06 Bn |
| Dec 31, 2022 | -328,000.00 |
| Sep 30, 2022 | -1.78 Bn |
| Jun 30, 2022 | -1.64 Bn |
| Mar 31, 2022 | -1.63 Bn |
| Dec 31, 2021 | -132,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | 36,000.00 |
| Mar 31, 2021 | -57,000.00 |